Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

A Phase I Study of High Dose Omeprazole in Patients With Pancreatic Cancer Planning to Undergo Surgical Therapy for Evaluating Changes of Biomarkers

The purpose of this phase I trial is to evaluate the safety and feasibility of high dose omeprazole in patients with pancreatic cancer.

NCT#: NCT04930991
Study ID: 12368
Trial Phase: Phase I

Trial Sponsor: University of Oklahoma
Therapies Used in This Trial: Omeprazole

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Back to Trial Search